The purpose of this study is to explore the optimal treatment strategy for retained products of pregnancy. Compared with surgical treatment, prospectively observe whether drug-assisted expectant management until the right time for surgery reduce the occurrence of intrauterine adhesions, and thus protect fertility.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of Participants with Intrauterine Adhesions (IUA) at 3 Months Post-Treatment
Timeframe: At 3 months after completion of treatment (on the 16th-24th day of the third menstrual cycle post-treatment)
Number of Participants Requiring Secondary Surgical Evacuation
Timeframe: From initiation of treatment to 3 months post-treatment
Number of Participants Achieving Pregnancy within 1 Year after Attempting Conception
Timeframe: From the start of attempting pregnancy (after completion of treatment and at least one normal menstrual cycle) up to 1 year